Monday July 16, 2018
Home Uncategorized All accused i...

All accused in Dadri lynching case arrested

0
//
27
Republish
Reprint

Lucknow: The tenth and last accused from Dadri lynching case where a Muslim man was beaten to death in Dadri, Uttar Pradesh, was arrested, police said on Monday.

The accused Hari Om, was holed up at a relative’s house in Sardhana town of western Uttar Pradesh and was picked up by police late Sunday following a tip-off by an informer.

Dadri Circle Officer (CO) Anurag Singh, while confirming the arrest, said Hari Om was the last of the ten accused in lynching of 50-year-old Mohammad Akhlaq, who was killed by a mob in Bisahada village on September 28.

Police had put his phone on surveillance and after his location was detected, a police team raided the house and arrested him.

Soon after the Dadri lynching, the six accused — Shri Om, Vivek, Gaurav, Saurabh, Sandip and Rupendra had been arrested, and another two — Shivam and Vishal were arrested two days after the incident, police officials told IANS.

Vishal is son of a local Bharatiya Janata Party (BJP) leader. The ninth accused, a minor, was arrested from Delhi on October 12 and now, the last accused has also been apprehended.

Akhlaq was beaten to death by an angry mob on September 28, while his son Danish was injured seriously after announcements were made from a nearby temple that the family had consumed beef.

The incident sparked off an outrage across the country.

(IANS)

Click here for reuse options!
Copyright 2015 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)

Next Story